Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CDON pseudogene 1 (CDONP1) is annotated as a pseudogene in the human genome. Pseudogenes are genomic sequences similar to known genes but are typically non-functional due to mutations preventing their expression as functional proteins[2][4]. Unlike its protein-coding counterpart CDON—which acts as a Hedgehog pathway co-receptor and has defined roles in cell differentiation, embryonic development, and disease—the pseudogene variant CDONP1 does not encode a functional cell-surface receptor and is not involved in signal transduction or cellular adhesion[2][3][5]. Pseudogenes can sometimes play regulatory roles through transcriptional interference, RNA binding, or as competitive endogenous RNAs (ceRNAs), but there is currently no evidence for such a function for CDONP1 specifically[2]. It is not considered a therapeutic target, receptor, or biomarker. Clarification / Caution: - is_incorrect = true because CDONP1 is a pseudogene, not a drug target, receptor, or enzyme. Literature and database references to drug targets for "CDON pseudogene 1" are likely mistaken, or are confusing it with the protein-coding CDON gene[3][5]. - If what is desired is information about the *functional, druggable receptor* CDON (Cell adhesion molecule-related/down-regulated by oncogenes), then the correct canonical target would be "CDON (Cell adhesion molecule-related/down-regulated by oncogenes receptor)"[3][5][1]. - Pseudogenes generally are not assigned biological functions, roles in disease, or mechanisms of drug action, unless there is explicit experimental evidence—which is currently lacking for CDONP1[2][4]. If your query refers to the functional receptor (CDON), please clarify, as this entry concerns only the pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CDON pseudogene 1 (CDONP1).